The therapeutic potential of VCE-004.8 in the treatment of Sclerodermia is published in Scientific Reports

18/02/2016

Córdoba, February 18th of 2016. The therapeutic potential of VCE-004.8 in the treatment of Sclerodermia is published in the renowned scientific journal Scientific Reports. The scientific paper shows the mechanism of action of VCE-004.8 on molecular targets for sclerodermia, and the therapeutic benefit that the treatment induces in mice models of this disease.

The scientific work has been coordinated by researches of Institute Maimónides of  Health Research at Córdoba (IMIBIC, Spain) and VivaCell, in collaboration with the Institute of Neurochemistry Research of the University Complutense of Madrid (Spain), the Network of Research in Neurodegenerative Diseases (CIBERNED, Madrid, Spain), the Institute Ramón y Cajal of Health Research (IRYCIS, Madrid, Spain), and the Department of Chemistry Sciences at the University of the Piamonte Orientale (Italy).

Más información:

Developed with DoPlanning